Ethics Committee

 

 

The ethics committee, according to Directive 2001/20/EC, is an independent body in a member state of the European Union, consisting of healthcare professionals and non-medical members, whose responsibility is to protect the rights, safety and well being of human subjects involved in a clinical trial and to provide public assurance of that protection, by, among other things, expressing an opinion on the clinical trial protocol, the suitability of the investigators involved in the trial and the adequacy of facilities, and on the methods and documents to be used to inform trial subjects and obtain their informed consent.

The main reference for the decisions and the general activity of an Ethics Committee is constituted by the Declaration of Helsinki (in its latest version) and the Convention of Oviedo. Secondly, the recommendations of the National Bioethics Committee are relevant. As for trials of medicinal products it is expected to refer to the rules laid down by the Good Clinical Practice in its latest version. An obvious reference are also the national and international laws according to the updated guidelines of the European Agency for the Evaluation of Medicinal Products concerning the evaluation of the effectiveness of clinical trials. Finally, they will also be considered as a valid scientific-methodological reference the feedback from existing scientific biography on the subject of investigation.

The purpose is to ensure:

  • the feasibility of a research project in terms of fairness and ethics of scientific experimentation;
  • the protection of the rights of the parties taking part in the clinical trial;
  • the adequacy of the relationship between the center at which research is conducted and the study sponsor (the sponsor is the person, company, institution or organization which takes responsibility for the initiation, management and / or financing of a clinical trial).

The Article 3 of the Italian Law of 12 May 2006 defines the guarantees that must be met for it to be recognized independence of the Ethics Committee. Conditions:

  • There must be a lack of hierarchical subordination of the Committee in respect of the structure where it operates.
  • It must be ensured the presence of personnel not employed by the property where the work of the Committee.
  • There should be a total absence of conflicts of interest of the voters with respect to the proposed trial.
  • There must not be a co-competing of an economic nature between the members of the committee and companies in the pharmaceutical sector.

 

 

Internal members:
Prof. Bartolomeo Sammartino, President
Prof. Francesco Cappello, Secretary
Avv. Antonio Congedo, Member
Dr. Antonina Sidoti, Member
Dr. Fedele Termini, Member

 

External Members:
Prof. Aldo Gerbino
Dr.ssa Virginia Coda Nunziante
Dr. Pier Luigi San Biagio
Don Giuseppe Di Giovanni

 

 

Rules about Research involving Human Subjects (attachment)

Rules about Research involving Animals (attachment)

 

 

5x1000

5x1000

Job opportunities

News

Lo I.E.ME.S.T. presenta il GR.IN. Cluster al Green Conservation of Cultural Hertitage
L' Istituto I.E.ME.S.T. ha collaborato all'organizzazione della Terza Conferenza Internazionale  "Green Conservation of Cultural Heritage", dove 250 ricercatori provenienti da 19 Paesi si sono confrontati sulle tematiche dello sviluppo sostenibile.In particolare la delegazione del Dipartimento NIMA (NanoInnovative Materials), ha presentato il Cluster GR.IN. ottenendo entusiastica adesione da parte di numerosi Partner Europei.

BANDO PER LA SELEZIONE
DI IDEE E PROGETTI
INNOVATIVI
CALL FOR PROPOSALS
“WORKING INTELLIGENCE,
SPREADING KNOWLEDGE”

 


 

Subscribe to Newsletter

Social Networks

WebMail

Privacy

Privacy